DrugPatentWatch Database Preview
Botulinum toxin type b - Biologic Drug Details
Try a free trialSee Plans and Pricing
Summary for botulinum toxin type b
| Tradenames: | 1 |
| Patents: | 73 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for botulinum toxin type b |
Pharmacology for botulinum toxin type b
| Mechanism of Action | Acetylcholine Release Inhibitors |
US Patents for botulinum toxin type b
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elan Pharm | MYOBLOC | botulinum toxin type b | VIAL | 103846 | 001 | 2000-12-08 | ➤ Try a Free Trial | Allergan, Inc. (Irvine, CA) | ➤ Try a Free Trial | RX | search | |
| Elan Pharm | MYOBLOC | botulinum toxin type b | VIAL | 103846 | 001 | 2000-12-08 | ➤ Try a Free Trial | Allergan, Inc. (Irvine, CA) | ➤ Try a Free Trial | RX | search | |
| Elan Pharm | MYOBLOC | botulinum toxin type b | VIAL | 103846 | 001 | 2000-12-08 | ➤ Try a Free Trial | ➤ Try a Free Trial | RX | search | ||
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for botulinum toxin type b
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2004041303 | ➤ Try a Free Trial |
| Spain | 2237033 | ➤ Try a Free Trial |
| China | 100401069 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for botulinum toxin type b
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB10/013 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: BOTULINUM TOXIN TYPE B; REGISTERED: UK EU/1/00/166/001-003 20010125 |
| 780 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826 |
| 13/025 | Ireland | ➤ Try a Free Trial | PRODUCT NAME: BOTULINUM TOXIN TYPE A; NAT REGISTRATION NO/DATE: PA0148/060/001 20130117; FIRST REGISTRATION NO/DATE: PA018/060/002 17/01/2013 IRELAND PA0148/060/003 17/01/2013 FINLAND 25162 16/01/2013 FINLAND 15424 16/01/2013 FINLAND 28146 20130116 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
